Skip to main content

Gennev is covered by insurance companies. Check if you are in network now.

Hormone replacement therapy (HRT) is often discussed in the context of increased breast cancer risk, but some evidence suggests it may also offer protective benefits against cancers including breast, colorectal and endometrial cancer. This webinar will explore the complex relationship between HRT and cancer risk during menopause, including how to evaluate potential benefits and risks when guiding patients through treatment decisions.